These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37002492)

  • 1. IL-17A inhibits the degradation of RANKL in osteoblasts by inhibiting BCL2-Beclin1-autophagy signaling.
    Chen XX; Wu HJ; Ke DS; Zhu YR
    In Vitro Cell Dev Biol Anim; 2023 Apr; 59(4):300-311. PubMed ID: 37002492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin suppresses RANKL-induced osteoclast precursor autophagy in osteoclastogenesis by inhibiting RANK signaling and downstream JNK-BCL2-Beclin1 pathway.
    Ke D; Xu H; Han J; Dai H; Wang X; Luo J; Yu Y; Xu J
    Biomed J; 2024 Feb; 47(1):100605. PubMed ID: 37179010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNK1 regulates RANKL-induced osteoclastogenesis
    Ke D; Ji L; Wang Y; Fu X; Chen J; Wang F; Zhao D; Xue Y; Lan X; Hou J
    FASEB J; 2019 Oct; 33(10):11082-11095. PubMed ID: 31295022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17A regulates autophagy and promotes osteoclast differentiation through the ERK/mTOR/Beclin1 pathway.
    Tang H; Zhu S; Chen K; Yuan S; Hu J; Wang H
    PLoS One; 2023; 18(2):e0281845. PubMed ID: 36795736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis.
    Ke D; Yu Y; Li C; Han J; Xu J
    Mol Med; 2022 Feb; 28(1):22. PubMed ID: 35183115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17A modulates osteoclast precursors' apoptosis through autophagy-TRAF3 signaling during osteoclastogenesis.
    Xue Y; Liang Z; Fu X; Wang T; Xie Q; Ke D
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1088-1092. PubMed ID: 30553450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactoferrin promotes the autophagy activity during osteoblast formation via BCL2-Beclin1 signaling.
    Ke D; Wang X; Lin Y; Wei S
    Mol Biol Rep; 2022 Jan; 49(1):259-266. PubMed ID: 34716503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-17 promotes osteoclastogenesis and periodontal damage via autophagy in vitro and in vivo.
    Zhong J; Wang Z; Yuan W; Shen Y; Chen L
    Int Immunopharmacol; 2022 Jun; 107():108631. PubMed ID: 35219162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17A regulates the autophagic activity of osteoclast precursors through RANKL-JNK1 signaling during osteoclastogenesis in vitro.
    Ke D; Fu X; Xue Y; Wu H; Zhang Y; Chen X; Hou J
    Biochem Biophys Res Commun; 2018 Mar; 497(3):890-896. PubMed ID: 29476739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17A inhibits autophagic activity of HCC cells by inhibiting the degradation of Bcl2.
    Li S; Lin Z; Zheng W; Zheng L; Chen X; Yan Z; Cheng Z; Yan H; Zheng C; Guo P
    Biochem Biophys Res Commun; 2019 Jan; 509(1):194-200. PubMed ID: 30579601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide inhibits osteoblast formation and receptor activator of nuclear factor-κB ligand degradation via autophagy inhibition.
    Zhang H; Lin J; Chen X; Dai J; Lin H
    Endocr J; 2024 Apr; 71(4):417-427. PubMed ID: 38355125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts.
    Zhang F; Tanaka H; Kawato T; Kitami S; Nakai K; Motohashi M; Suzuki N; Wang CL; Ochiai K; Isokawa K; Maeno M
    Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synergistic effects of IL-6/IL-17A promote osteogenic differentiation by improving OPG/RANKL ratio and adhesion of MC3T3-E1 cells on hydroxyapatite.
    Sritharan S; Kannan TP; Norazmi MN; Nurul AA
    J Craniomaxillofac Surg; 2018 Aug; 46(8):1361-1367. PubMed ID: 29805067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17 prevents oxidative stress from damaging osteoblast formation by inhibiting autophagic degradation of metallothionein-2.
    Ling X; Wang C; Feng Q; Zhang T
    Endocr J; 2024 Jun; 71(6):623-633. PubMed ID: 38644219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and -independent autophagic responses.
    Zhang G; Wang Y; Tang G; Ma Y
    BMC Complement Altern Med; 2019 Oct; 19(1):269. PubMed ID: 31615565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy mediated by JNK1 resists apoptosis through TRAF3 degradation in osteoclastogenesis.
    Ke D; Zhu Y; Zheng W; Fu X; Chen J; Han J
    Biochimie; 2019 Dec; 167():217-227. PubMed ID: 31654668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rubiadin-1-methyl ether inhibits BECN1 transcription and Beclin1-dependent autophagy during osteoclastogenesis by inhibiting NF-κB p65 activation.
    Cai S; Chen Y; Chen J; Wei W; Pan J; Wu H
    Exp Biol Med (Maywood); 2023 Sep; 248(17):1518-1526. PubMed ID: 37750211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD142 promotes trophoblast cell migration by inhibiting BCL2-related autophagic degradation of IL-8.
    Zheng L; Tang R; Shi L; Zhou Z; Song J; Lu Z
    In Vitro Cell Dev Biol Anim; 2023 Feb; 59(2):131-141. PubMed ID: 36847889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
    Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
    PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DUSP4 inhibits autophagic cell death and apoptosis in colorectal cancer by regulating BCL2-Beclin1/Bax signaling.
    Xu W; Nie C; Chen X
    Mol Biol Rep; 2023 Apr; 50(4):3229-3239. PubMed ID: 36705792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.